1734 related articles for article (PubMed ID: 17996660)
1. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
2. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
3. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia.
Zuidema SU; Derksen E; Verhey FR; Koopmans RT
Int J Geriatr Psychiatry; 2007 Jul; 22(7):632-8. PubMed ID: 17136713
[TBL] [Abstract][Full Text] [Related]
5. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
7. Low-dose divalproex in agitated patients with Alzheimer's disease.
Dolder C; McKinsey J
J Psychiatr Pract; 2010 Jan; 16(1):63-7. PubMed ID: 20098234
[TBL] [Abstract][Full Text] [Related]
8. Agitated behaviours among the institutionalized elderly with dementia: validation of the Korean version of the Cohen-Mansfield Agitation Inventory.
Suh GH
Int J Geriatr Psychiatry; 2004 Apr; 19(4):378-85. PubMed ID: 15065232
[TBL] [Abstract][Full Text] [Related]
9. Agitation in Dutch institutionalized patients with dementia: factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory.
Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
Dement Geriatr Cogn Disord; 2007; 23(1):35-41. PubMed ID: 17077631
[TBL] [Abstract][Full Text] [Related]
10. Verbal and physical non-aggressive agitated behaviors in elderly persons with dementia: robustness of syndromes.
Cohen-Mansfield J; Libin A
J Psychiatr Res; 2005 May; 39(3):325-32. PubMed ID: 15725431
[TBL] [Abstract][Full Text] [Related]
11. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
12. [Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)].
Shigenobu K; Hirono N; Tabushi K; Ikeda M
Brain Nerve; 2008 Dec; 60(12):1463-9. PubMed ID: 19110758
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes.
Testad I; Aasland AM; Aarsland D
Int J Geriatr Psychiatry; 2007 Sep; 22(9):916-21. PubMed ID: 17323402
[TBL] [Abstract][Full Text] [Related]
14. A pilot study on a home-based caregiver training program for improving caregiver self-efficacy and decreasing the behavioral problems of elders with dementia in Taiwan.
Huang HL; Shyu YI; Chen MC; Chen ST; Lin LC
Int J Geriatr Psychiatry; 2003 Apr; 18(4):337-45. PubMed ID: 12673611
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
Conney J; Kaston B
Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
[TBL] [Abstract][Full Text] [Related]
16. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients.
Shankle WR; Nielson KA; Cotman CW
Alzheimer Dis Assoc Disord; 1995; 9(4):233-7. PubMed ID: 8749613
[TBL] [Abstract][Full Text] [Related]
17. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
Mintzer JE; Brawman-Mintzer O
J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
[TBL] [Abstract][Full Text] [Related]
18. Opioid treatment for agitation in patients with advanced dementia.
Manfredi PL; Breuer B; Wallenstein S; Stegmann M; Bottomley G; Libow L
Int J Geriatr Psychiatry; 2003 Aug; 18(8):700-5. PubMed ID: 12891637
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
20. Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia.
Meinhold JM; Blake LM; Mini LJ; Welge JA; Schwiers M; Hughes A
Drugs Aging; 2005; 22(7):615-26. PubMed ID: 16038575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
